site stats

Ginkgo bioworks financials

WebApr 14, 2024 · Ginkgo Bioworks Holdings Inc. (NYSE:DNA) shares, rose in value on Thursday, 04/13/23, with the stock price up by 3.13% to the previous day’s close as strong demand from buyers drove the stock to $1.32. Actively observing the price movement in the last trading, the stock closed the session at $1.28, falling within a range of $1.28 and $1.35. WebFeb 8, 2024 · The foundry revenue for Q3 2024 was recorded as $25 million, a decrease of 29% from Q3 2024, owing to the absence of large milestone payments. Ginkgo's R&D expenses increased to $73 million, …

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

WebApr 14, 2024 · In other Ginkgo Bioworks news, major shareholder Barry Canton sold 151,530 shares of the stock in a transaction on Tuesday, January 17th. The stock was sold at an average price of $1.86, for a ... WebWith Ginkgo Bioworks Holdings stock trading at $1.33 per share, the total value of Ginkgo Bioworks Holdings stock (market capitalization) is $2.76B. Ginkgo Bioworks Holdings stock was originally listed at a price of $10.88 in Feb 24, 2024. If you had invested in Ginkgo Bioworks Holdings stock at $10.88, your return over the last 2 years would ... harrowby road wirral https://mcmanus-llc.com

Ginkgo Bioworks Reports Fourth Quarter and Full Year …

WebApr 13, 2024 · Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across … WebGinkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Foundry ... Web1 day ago · Find the latest Ginkgo Bioworks Holdings Inc (DNA US37611X1000) company financial and reports plus latest price, trades, performance, company information and news ... If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to … charging tesla at home australia

Ginkgo Bioworks Reports Fourth Quarter and Full Year …

Category:Ginkgo Bioworks Holdings Inc (DNA) Stock Price & News

Tags:Ginkgo bioworks financials

Ginkgo bioworks financials

Ginkgo Bioworks Reports Third Quarter 2024 Financial Results

WebApr 18, 2024 · Without a doubt, expanding the number of new cell programs contributed to Ginkgo Bioworks’ financial success during 2024’s fourth quarter. In that time frame, the company managed to increase its revenue year-over-year by a whopping 363%, to $148 million. Q4 wasn’t just a fluke, either. For Fiscal 2024, Ginkgo Bioworks pulled in total ... WebApr 5, 2024 · Corporate Profile. Headquartered in Boston, Ginkgo Bioworks is building a platform to enable customers to program cells as easily as we can program computers. …

Ginkgo bioworks financials

Did you know?

WebDec 31, 2014 · View the latest Ginkgo Bioworks Holdings Inc. (DNA) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebGet the detailed quarterly/annual income statement for Ginkgo Bioworks Holdings, Inc. (DNA). Find out the revenue, expenses and profit or loss over the last fiscal year.

WebApr 9, 2024 · Several other hedge funds have also recently modified their holdings of the stock. Clarius Group LLC purchased a new position in Ginkgo Bioworks during the fourth quarter worth about $30,000. Phillips Financial Management LLC acquired a new stake in shares of Ginkgo Bioworks in the 4th quarter valued at approximately $25,000. WebNov 14, 2024 · Third Quarter 2024 Financial Highlights. Third quarter 2024 Total revenue of $66 million, down from $78 million in the comparable prior year period, a decrease of …

WebGinkgo Bioworks Holdings Inc. annual income statement. View DNA financial statements in full, including balance sheets and ratios. Dow Jones, a News Corp company About WSJ WebPhone Number +1 877 422 5362. Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals.

WebApr 14, 2024 · In other Ginkgo Bioworks news, major shareholder Barry Canton sold 151,530 shares of the stock in a transaction on Tuesday, January 17th. The stock was …

WebFeb 26, 2024 · Senior Director, Financial Systems @ Gingko Bioworks New York City Metropolitan Area. 600 followers ... So excited for Ginkgo … charging tesla at home costWebMar 28, 2024 · Ginkgo Bioworks Holdings, Inc., the leading horizontal platform for cell programming, announced its results for the fourth quarter and year ended December 31, … charging tesla at home electric billWeb1 day ago · Find the latest Ginkgo Bioworks Holdings Inc (DNA US37611X1000) company financial and reports plus latest price, trades, performance, company … harrowby street boltonWebGinkgo Bioworks has raised a total of $350M in a single venture fund, The Ferment Fund. This fund was announced on Oct 9, 2024 and raised a … charging teslacharging tesla carsWebNov 14, 2024 · Ginkgo further revised its expectation for Total revenue from $425 – $440 million to $460 – $480 million in 2024. Ginkgo revised its expectation for Foundry … charging tesla home accessoriesWebMar 23, 2024 · Detailed financial statements for Ginkgo Bioworks Holdings (DNA), including the income statement, balance sheet, and cash flow statement. ... Ginkgo Bioworks Holdings, Inc. (DNA) NYSE: DNA · IEX Real-Time Price · USD. Add to Watchlist 1.26 +0.04 (3.28%) Mar 23, 2024, 9:42 AM EDT - Market open. Overview; harrowby street farnworth